CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caption Management, LLC | 536,100 | $7,993,251 | 0.12% |
Corton Capital Inc. | 16,080 | $239,753 | 0.12% |
Bayesian Capital Management, LP | 67,400 | $1,004,934 | 0.12% |
Caption Management, LLC | 490,600 | $7,314,846 | 0.11% |
Point72 Asset Management, L.P. | 2,429,924 | $36,230,167 | 0.11% |
Virtus ETF Advisers LLC | 11,343 | $169,124 | 0.10% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 38,894 | $579,910 | 0.10% |
Atom Investors LP | 24,538 | $365,862 | 0.08% |
Trexquant Investment LP | 219,755 | $3,276,547 | 0.08% |
ClariVest Asset Management LLC | 96,481 | $1,438 | 0.08% |
J. Goldman & Co LP | 138,949 | $2,071,730 | 0.07% |
SEVEN EIGHT CAPITAL, LP | 41,556 | $619,600 | 0.07% |
Woodline Partners LP | 410,715 | $6,123,761 | 0.07% |
J. Goldman & Co LP | 135,000 | $2,012,850 | 0.07% |
Hennion & Walsh Asset Management, Inc. | 72,839 | $1,086,029 | 0.07% |
JANUS HENDERSON GROUP PLC | 6,803,484 | $101,432,021 | 0.07% |
ALGERT GLOBAL LLC | 92,886 | $1,385 | 0.06% |
Campbell & CO Investment Adviser LLC | 36,115 | $538,475 | 0.06% |
XTX Topco Ltd | 18,576 | $276,968 | 0.05% |
JENNISON ASSOCIATES LLC | 3,555,274 | $53,009,135 | 0.04% |
External links
This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.